Go4it; study design of a randomised controlled trial and economic evaluation of a multidisciplinary group intervention for obese adolescents for prevention of diabetes mellitus type 2

Bovet, Pascal; Gervasoni, Jean-Pierre; Mkamba, Mashombo; Balampama, Marianna; Lengeler, Christian; Paccaud, Fred
January 2008
BMC Public Health;2008, Vol. 8 Issue 1, p410
Academic Journal
Background: In the Netherlands, the first adolescents with diabetes mellitus type 2 as a result of obesity have recently been diagnosed. Therefore, it is very important that programs aiming at the prevention of type 2 diabetes of obese adolescents are developed and evaluated. Methods: Go4it is a multidisciplinary group treatment that focuses on: 1) increasing awareness of the current dietary and physical activity behaviour (i.e. energy balance behaviour), 2) improving diet, 3) decreasing sedentary behaviour, 4) increasing levels of physical activity, and 5) coping with difficult situations. Go4it consists of 7 sessions with an interval of 2-3 weeks. The effectiveness of the multidisciplinary group treatment compared with usual care (i.e. referral to a dietician) was evaluated in a randomised controlled trial. We examined effects on BMI(sds), body composition, energy expenditure, glucose tolerance and insulin resistance (primary outcome measure), as well as dietary and physical activity behaviour and quality of life. An economic evaluation from a societal perspective was conducted alongside the randomised trial to evaluate the cost-effectiveness of the multidisciplinary treatment program vs. usual care. Discussion: In this paper we described a multidisciplinary treatment program (Go4it) for obese adolescents and the design of a randomised controlled trial and economic evaluation to evaluate its effectiveness and cost-effectiveness. Trial registration: Netherlands Trial Register (ISRCTN27626398).


Related Articles

  • Possibilities for prevention. Rafkin, Lisa // Countdown;Summer98, Vol. 19 Issue 3, p18 

    Focuses on the Diabetes Prevention Trial-Type 1 (DPT-1), a randomized clinical trial conducted in the United States designed to determine whether it is possible to prevent or delay the onset of Type 1 diabetes. Sponsors of the trials; Eligible participants in the insulin injection trial.

  • Are Diabetes Prevention Treat-ments Truly Disease Modifying?  // Internal Medicine Alert;Aug2011 Clinical Briefs in Primary, p16 

    The article reports on the Heart Outcomes Prevention Evaluation trial that aims to reduce conversion from pre-diabetes to type 2 diabetes (DM2).

  • Prevention trial for Type I diabetes.  // Diabetes Forecast;Sep95, Vol. 48 Issue 9, p77 

    Calls for participants to a study launched by the National Institutes of Health to test whether daily insulin injections will prevent diabetes. Genetic risks of developing type I diabetes; Eligible participants; Steps on how to participate.

  • Prevention of Diabetes.  // OB/GYN Clinical Alert;Sep2012 Clinical Briefs in Primary Care, p18 

    The article discusses the clinical trials of various drugs such as metformin and thiazolidinedione for the prevention of diabetes.

  • Interferon Alpha Can Delay Full Onset of Type 1 Diabetes.  // Diabetes Health;Oct/Nov2009, Vol. 18 Issue 5, p38 

    The article reports on a phase II clinical trial performed at the University of Texas Medical School which revealed that a low dose of oral interferon alpha can delay the full onset of type 1 diabetes.

  • Prevention of type 2 diabetes. Narayan, K M Venkat; Bowman, Barbara A; Engelgau, Michael E // BMJ: British Medical Journal (International Edition);7/14/2001, Vol. 323 Issue 7304, p63 

    Editorial. Discusses a randomised controlled clinical trial in Finland which studied prevention of type two diabetes. Behavioural and environmental factors which have been linked to type two diabetes, such as overweight, physical inactivity, and dietary habits; Conclusion of the report that...

  • TRIGR: First ever trial for the primary prevention of T1D.  // Diabetes Digest;2011, Vol. 10 Issue 3, p141 

    The article discusses a Trial to Reduce IDDM in the Genetically at Risk (TRIGR) study by H. K. Akerblom and colleagues on whether weaning babies with high hydrolised formula can reduce the risk of type 1 diabetes (T1D).

  • The Nutrition and Enjoyable Activity for Teen Girls (NEAT girls) randomized controlled trial for adolescent girls from disadvantaged secondary schools: rationale, study protocol, and baseline results. Lubans, David R.; Morgan, Philip J.; Dewar, Deborah; Collins, Clare E.; Plotnikoff, Ronald C.; Okely, Anthony D.; Batterham, Marijka J.; Finn, Tara; Callister, Robin // BMC Public Health;2010, Vol. 10 Issue 1, p652 

    Background: Child and adolescent obesity predisposes individuals to an increased risk of morbidity and mortality from a range of lifestyle diseases. Although there is some evidence to suggest that rates of pediatric obesity have leveled off in recent years, this has not been the case among youth...

  • THE TOP 7 Hit List.  // LocumLife;Aug2010, Vol. 6 Issue 2, p2 

    A list of the top seven issues featured in 2010 issues of this magazine is presented including diabetes prevention, adult obesity, and breast masses in adolescent girls.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics